Search - tctmd.com

Displaying 1 - 20 of 21

Sort: Relevancy | Date

Presentation TCT 2017

DCB Under Development: Alternative Drugs and Local Delivery Methods

Presenter: Sahil A. Parikh, Thomas Zeller, William A. Gray

November 01, 2017

Presentation TCT 2017

DCB Versus DES for SFA Disease: Data Review and Future Clinical Trials

Presenter: Sahil A. Parikh, Thomas Zeller, Jihad A. Mustapha

November 01, 2017

Presentation TCT 2017

DCB for Long Lesions and Highly Calcified Vessels II: Are Outcomes Improved With Non-Atherectomy Approaches (Scoring, Cutting, Lithoplasty, and More)

Presenter: Sahil A. Parikh, Thomas Zeller, Peter A. Schneider

November 01, 2017

Presentation TCT 2017

DCB for Long Lesions and Highly Calcified Vessels I: Are Outcomes Improved by Routine Atherectomy?

Presenter: Sahil A. Parikh, Thomas Zeller, Krishna J. Rocha-Singh

November 01, 2017

Presentation TCT 2017

DCB Data in Specific Lesion Subsets: ISR, CTO, and Beyond

Presenter: Sahil A. Parikh, Thomas Zeller

November 01, 2017

Presentation TCT 2017

DCB Data in Real-world Registries: Back to Reality?

Presenter: Sahil A. Parikh, Thomas Zeller, Gary M. Ansel

November 01, 2017

Presentation TCT 2017

Impact of DCB Technique on Long-term Vessel Patency: Can Clinical Outcomes Be Optimized?

Presenter: William A. Gray, Thomas Zeller

November 01, 2017

Presentation TCT 2017

Long-term Data With Lower-Dose DCB Technologies (LEVANT, ILLUMINATE, RANGER)

Presenter: William A. Gray, Thomas Zeller, Mitchell Weinberg

November 01, 2017

Presentation TCT 2017

Long-Term Data With Standard-Dose DCB Technologies (IN.PACT SFA and the Consequent Trial)

Presenter: William A. Gray, Thomas Zeller, Peter A. Schneider

November 01, 2017

Presentation TCT 2017

DCB Architecture: Technical Features Determining Long-term Safety and Efficacy

Presenter: William A. Gray, Thomas Zeller, Juan F. Granada

November 01, 2017

Presentation TCT 2017

Multilevel Disease: How Does BTK Disease Affect ATK Therapy?

Presenter: D. Christopher Metzger, Thomas Zeller, Tony Das

October 31, 2017

Presentation TCT 2017

Treating Long, Calcified Lesions, the Achilles Heel for Endovascular Therapy

Presenter: D. Christopher Metzger, Thomas Zeller, Nicolas W Shammas

October 31, 2017

Presentation TCT 2017

Does Lesion Length Affect Treatment Choice in the Fem-pop Segment?

Presenter: D. Christopher Metzger, Thomas Zeller, William A. Gray

October 31, 2017

Presentation TCT 2017

Crossing and Treating Long Lesions: Does the True Lumen Matter for Drug Delivery?

Presenter: D. Christopher Metzger, Thomas Zeller

October 31, 2017

Presentation TCT 2017

Drug Eluting Scaffold With an Absorbable Platform for Primary Lower Extremity Arterial Revascularization DESappear Study Initial Results

Presenter: Tony Das, Thomas Zeller

October 30, 2017

Presentation TCT 2017

Percutaneous Femoropopliteal Bypass Using the Novel PQ Bypass DETOUR Procedure for Long-Segment Disease: Interim Safety and Efficacy Data from the DETOUR I Trial

Presenter: Tony Das, Thomas Zeller, Grzegorz Halena, MD

October 30, 2017

Presentation TCT 2017

The BioMimics 3DTM Stent System in the Femoropopliteal Arteries of Patients With Symptomatic Peripheral Arterial Disease: Clinical and Angiographic Performance in the MIMICS-2 Study

Presenter: Tony Das, Thomas Zeller, Georgios Bouras

October 30, 2017

Presentation TCT 2017

The PRELUDE Study: Prospective Study for the Treatment of Atherosclerotic Lesions in the Superficial Femoral and/or Popliteal Arteries Using the Serranator® Device

Presenter: Tony Das, Thomas Zeller, William A. Gray

October 30, 2017

Presentation VIVA 2017

Two-year Results from the IN.PACT Global Study

Presenter: Thomas Zeller

September 14, 2017

News Conference News VIVA 2017

DCBs, Stents, and ‘Swirling Flow’ Show Promise in Femoropopliteal Disease

L.A. McKeown

September 13, 2017

Advertisement

DCB Under Development: Alternative Drugs and Local Delivery Methods

DCB Versus DES for SFA Disease: Data Review and Future Clinical Trials

DCB for Long Lesions and Highly Calcified Vessels II: Are Outcomes Improved With Non-Atherectomy Approaches (Scoring, Cutting, Lithoplasty, and More)

DCB for Long Lesions and Highly Calcified Vessels I: Are Outcomes Improved by Routine Atherectomy?

DCB Data in Specific Lesion Subsets: ISR, CTO, and Beyond

DCB Data in Real-world Registries: Back to Reality?

Impact of DCB Technique on Long-term Vessel Patency: Can Clinical Outcomes Be Optimized?

Long-term Data With Lower-Dose DCB Technologies (LEVANT, ILLUMINATE, RANGER)

Long-Term Data With Standard-Dose DCB Technologies (IN.PACT SFA and the Consequent Trial)

DCB Architecture: Technical Features Determining Long-term Safety and Efficacy

Multilevel Disease: How Does BTK Disease Affect ATK Therapy?

Treating Long, Calcified Lesions, the Achilles Heel for Endovascular Therapy

Does Lesion Length Affect Treatment Choice in the Fem-pop Segment?

Crossing and Treating Long Lesions: Does the True Lumen Matter for Drug Delivery?

Drug Eluting Scaffold With an Absorbable Platform for Primary Lower Extremity Arterial Revascularization DESappear Study Initial Results

Percutaneous Femoropopliteal Bypass Using the Novel PQ Bypass DETOUR Procedure for Long-Segment Disease: Interim Safety and Efficacy Data from the DETOUR I Trial

The BioMimics 3DTM Stent System in the Femoropopliteal Arteries of Patients With Symptomatic Peripheral Arterial Disease: Clinical and Angiographic Performance in the MIMICS-2 Study

The PRELUDE Study: Prospective Study for the Treatment of Atherosclerotic Lesions in the Superficial Femoral and/or Popliteal Arteries Using the Serranator® Device

Two-year Results from the IN.PACT Global Study

DCBs, Stents, and ‘Swirling Flow’ Show Promise in Femoropopliteal Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content